Familial hypercholesterolaemia: clinical features and management

Area of Science:

• Cardiology
• Genetics
• Public Health

Background:

• Coronary heart disease (CHD) is a primary cause of death and illness in the UK.
• Hypercholesterolaemia is a significant risk factor for developing CHD.
• Familial hypercholesterolaemia (FH) represents a common, yet often undiagnosed, genetic contributor to high cholesterol levels.

Purpose of the Study:

• To provide a comprehensive overview of familial hypercholesterolaemia (FH).
• To detail the diagnostic criteria and methods for identifying FH.
• To outline current and emerging treatment options for managing FH.

Main Methods:

• Literature review of epidemiological data on CHD and hypercholesterolaemia in the UK.
• Analysis of diagnostic guidelines for FH.
• Synthesis of evidence-based treatment strategies for FH management.

Main Results:

• FH significantly elevates the risk of premature CHD.
• Early diagnosis through genetic screening and clinical assessment is crucial.
• A multi-faceted approach to management, including lifestyle changes and pharmacotherapy, is essential.

Conclusions:

• Effective management of FH is vital to reduce CHD morbidity and mortality in the UK.
• Timely diagnosis and consistent treatment adherence are key to improving patient outcomes.
• Further research into novel therapies for FH is warranted.